Teva and Medincell Announce Positive Efficacy Results for Phase 3 SOLARIS Trial of TEV-‘749 (olanzapine/mdc-TJK), Monthly Long-Acting Subcutaneous Injection for Adults With Schizophrenia – 08/05/ 2024 at 12:30
Covid-19: what do we know about intensive care patients? The new data from the AP-HP: Current Woman The MAG 12 January 20220 Covid-19: what do we know about intensive care patients? The new data from the AP-HP: Current Woman The MAG Path 2645DBCB3-7979-441A-BA4B-98E7BF17E1BE 1785B508-2A96-4CF5-AA87-79B0FE0441BF advertising source site-44